Journal issues > Issue Special, April 2025 > Lymphoma care in Belgium: Patient-reported outcomes

Lymphoma care in Belgium: Patient-reported outcomes

During the BHS meeting, Elke Stienissen (president Lymfeklierkanker Vereniging Vlaanderen vzw & chair BHS patient committee), Marijke Quaghebeur (nurse specialist UZ Ghent & member BHS nurses committee) and Dr. Marc André (haematologist CHU UCL Namur & BHS president) presented the Belgian results of the 2024 Global Patient Survey on Lymphomas and CLL. The survey aimed to assess the needs and challenges faced by lymphoma patients and their caregivers.1 During the presentation, the speakers focused on the results related to diagnosis and symptoms, healthcare information, treatment and care, and psychosocial impact.

To read the full artice you have the following options:

Click here to log in. Register for a free subscription*

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top